1. FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma. (1st July 2021) Authors: Kasamon, Yvette L.; Price, Lauren S.L.; Okusanya, Olanrewaju O.; Richardson, Nicholas C.; Li, Ruo-Jing; Ma, Lian; Wu, Yu-Te; Theoret, Marc; Pazdur, Richard; Gormley, Nicole J. Journal: Oncologist Issue: Volume 26:Number 10(2021) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism. Issue 1 (28th June 2015) Authors: Shim, Joong Sup; Li, Ruo-Jing; Lv, Junfang; Head, Sarah A.; Yang, Eun Ju; Liu, Jun O. Journal: Cancer letters Issue: Volume 362:Issue 1(2015) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation. Issue 3 (2nd February 2018) Authors: Fu, Chenglai; Tyagi, Richa; Chin, Alfred C.; Rojas, Tomas; Li, Ruo-Jing; Guha, Prasun; Bernstein, Isaac A.; Rao, Feng; Xu, Risheng; Cha, Jiyoung Y.; Xu, Jing; Snowman, Adele M.; Semenza, Gregg L.; Snyder, Solomon H. Journal: Circulation research Issue: Volume 122:Issue 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth. (28th November 2017) Authors: Lyu, Junfang; Yang, Eun Ju; Head, Sarah A.; Ai, Nana; Zhang, Baoyuan; Wu, Changjie; Li, Ruo-Jing; Liu, Yifan; Yang, Chen; Dang, Yongjun; Kwon, Ho Jeong; Ge, Wei; Liu, Jun O.; Shim, Joong Sup Journal: Cancer letters Issue: Volume 409(2017) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗